The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Sacks Natalie since year 2005.
The trader's CIK number is 1683811.
At the time of the last reporting, Sacks Natalie was the Chief Medical Officer of Harpoon Therapeutics, Inc. .
(stock ticker symbol HARP).
See this page for all insider trading activities at Harpoon Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-01||HARP||Harpoon Therapeutics, Inc.||Option Ex||5,826||2.12||12,351|
|2019-11-01||HARP||Harpoon Therapeutics, Inc.||Sale||5,826||13.16||76,699|
|2019-10-15||HARP||Harpoon Therapeutics, Inc.||Sale||11,698||13.21||154,483|
|2019-10-14||HARP||Harpoon Therapeutics, Inc.||Sale||12,452||13.27||165,275|
|2019-10-15||HARP||Harpoon Therapeutics, Inc.||Option Ex||11,698||2.12||24,799|
|2019-10-14||HARP||Harpoon Therapeutics, Inc.||Option Ex||12,452||2.12||26,398|
|2018-09-13||ADRO||Aduro Biotech, Inc.||Sale||3,028||6.50||19,678|
|2018-09-04||ADRO||Aduro Biotech, Inc.||Sale||4,504||7.13||32,100|
|2017-09-01||ADRO||Aduro Biotech, Inc.||Sale||4,885||11.71||57,198|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sacks Natalie (Chief Medical Officer of Harpoon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.